These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20551007)

  • 21. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.
    Rasbach LE; Atkins AE; Milaszewski KM; Keady J; Schmidt LM; Volkening LK; Laffel LM
    J Diabetes Sci Technol; 2014 May; 8(3):494-7. PubMed ID: 24876612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.
    Polonsky WH; Hessler D; Ruedy KJ; Beck RW;
    Diabetes Care; 2017 Jun; 40(6):736-741. PubMed ID: 28389582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trial.
    Hermanns N; Schumann B; Kulzer B; Haak T
    J Diabetes Sci Technol; 2014 May; 8(3):516-22. PubMed ID: 24876615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 25. Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive Value.
    Gilliam LK; Parker MM; Moffet HH; Lee AK; Karter AJ
    Diabetes Technol Ther; 2024 May; 26(5):298-306. PubMed ID: 38277155
    [No Abstract]   [Full Text] [Related]  

  • 26. Improvement of metabolic control after 3-month use of real-time continuous glucose monitoring in patients with type 1 diabetes: a multicenter study in Greece.
    Eleftheriadou I; Didangelos T; Pappas AC; Anastasiou E; Vasilopoulos C; Zoupas C; Manes C; Tsatsoulis A; Benroubi M; Pangalos E; Thomakos P; Gerasimidi-Vazeou A; Tentolouris N
    Hormones (Athens); 2019 Dec; 18(4):443-450. PubMed ID: 31721132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of asymptomatic drug-induced hypoglycemia using continuous glucose monitoring in older people - Systematic review.
    Mattishent K; Loke YK
    J Diabetes Complications; 2018 Aug; 32(8):805-812. PubMed ID: 29887300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users.
    Polonsky WH; Hessler D
    Diabetes Technol Ther; 2013 Apr; 15(4):295-301. PubMed ID: 23427866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.
    Pepper GM; Steinsapir J; Reynolds K
    Diabetes Technol Ther; 2012 Aug; 14(8):654-7. PubMed ID: 22690923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practice.
    Anderson J; Attvall S; Sternemalm L; Pivodic A; Fahlén M; Hanås R; Ekeroth G; Lind M
    J Diabetes Sci Technol; 2011 Nov; 5(6):1472-9. PubMed ID: 22226268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Association Between HbA
    Seyed Ahmadi S; Westman K; Pivodic A; Ólafsdóttir AF; Dahlqvist S; Hirsch IB; Hellman J; Ekelund M; Heise T; Polonsky W; Wijkman M; Schwarcz E; Lind M
    Diabetes Care; 2020 Sep; 43(9):2017-2024. PubMed ID: 32641374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous Glucose Monitor with Siri Integration Improves Glycemic Control in Legally Blind Patients with Diabetes.
    Akturk HK; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2021 Jan; 23(1):81-83. PubMed ID: 32758007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a pharmacist-led personal continuous glucose monitor workflow to improve glycemic management in an internal medicine clinic.
    Pasour T; Sheehan L; Troyer M; Conger M; Carson P
    J Am Pharm Assoc (2003); 2024; 64(4):102139. PubMed ID: 38823557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation between HbA1c and hypoglycemia revisited; a secondary analysis from an intervention trial in patients with type 1 diabetes and impaired awareness of hypoglycemia.
    van Beers CAJ; Caris MG; DeVries JH; Serné EH
    J Diabetes Complications; 2018 Jan; 32(1):100-103. PubMed ID: 29054335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation.
    Kesavadev J; Vigersky R; Shin J; Pillai PBS; Shankar A; Sanal G; Krishnan G; Jothydev S
    Adv Ther; 2017 Aug; 34(8):1918-1927. PubMed ID: 28667580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.
    Joubert M; Reznik Y
    Diabetes Res Clin Pract; 2012 Jun; 96(3):294-305. PubMed ID: 22209014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of continuous glucose monitoring in well-controlled type 1 diabetes.
    ; Beck RW; Hirsch IB; Laffel L; Tamborlane WV; Bode BW; Buckingham B; Chase P; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Huang ES; Kollman C; Kowalski AJ; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer SA; Wilson DM; Wolpert H; Wysocki T; Xing D
    Diabetes Care; 2009 Aug; 32(8):1378-83. PubMed ID: 19429875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.